Caveolae and caveolin in transmembrane signaling: Implications for human disease

被引:82
作者
Schwencke, C [1 ]
Braun-Dullaeus, RC [1 ]
Wunderlich, C [1 ]
Strasser, RH [1 ]
机构
[1] Tech Univ Dresden, Med Clin Cardiol, D-01307 Dresden, Germany
关键词
caveolae; caveolin; human disease; atherosclerosis; restenosis; malignancies;
D O I
10.1016/j.cardiores.2005.11.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The identification of various signaling molecules found within caveolae and their functional interaction with the integral membrane protein caveolin, a major structural component of caveolae, suggests that these membrane microdomains participate in transmembrane signaling. Several lines of evidence indicate that caveolin may act as a scaffolding protein by direct interaction with and modulation of the activity of multiple signaling molecules. The compartmentation of various signaling molecules in caveolae and their direct and functional interaction with caveolin provides a paradigm by which these membrane microdomains are involved in regulating signal transduction pathways. By dysregulation of these signal transduction pathways caveolins may be involved in the pathogenesis of various diseases. This review focuses on the implications as well as controversies of the contribution of caveolae and caveolins for several human diseases and the potential implications to therapeutic strategies. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:42 / 49
页数:8
相关论文
共 97 条
  • [11] Interaction of a receptor tyrosine kinase, EGF-R, with caveolins - Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
    Couet, J
    Sargiacomo, M
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) : 30429 - 30438
  • [12] Identification of peptide and protein ligands for the caveolin-scaffolding domain - Implications for the interaction of caveolin with caveolae-associated proteins
    Couet, J
    Li, SW
    Okamoto, T
    Ikezu, T
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) : 6525 - 6533
  • [13] Cui J, 2001, PROSTATE, V46, P249, DOI 10.1002/1097-0045(20010215)46:3<249::AID-PROS1030>3.0.CO
  • [14] 2-#
  • [15] Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
    Drab, M
    Verkade, P
    Elger, M
    Kasper, M
    Lohn, M
    Lauterbach, B
    Menne, J
    Lindschau, C
    Mende, F
    Luft, FC
    Schedl, A
    Haller, H
    Kurzchalia, TV
    [J]. SCIENCE, 2001, 293 (5539) : 2449 - 2452
  • [16] Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
    Dzau, VJ
    Braun-Dullaeus, RC
    Sedding, DG
    [J]. NATURE MEDICINE, 2002, 8 (11) : 1249 - 1256
  • [17] The muscular dystrophies
    Emery, AEH
    [J]. LANCET, 2002, 359 (9307) : 687 - 695
  • [18] Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1) -: Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines
    Engelman, JA
    Zhang, XL
    Lisanti, MP
    [J]. FEBS LETTERS, 1999, 448 (2-3): : 221 - 230
  • [19] Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
    Engelman, JA
    Zhang, XL
    Lisanti, MP
    [J]. FEBS LETTERS, 1998, 436 (03): : 403 - 410
  • [20] Fine SW, 2001, AM J CLIN PATHOL, V115, P719